Successful treatment of aggressive metastatic sebaceous carcinoma with pembrolizumab

This publication has 6 references indexed in Scilit:

• Treatment of high tumor mutation burden metastatic extramammary Paget disease with an anti–PD‐1 antibody
  The Journal of Dermatology, 2023
• Combination treatment of bilateral periocular sebaceous carcinomas with microsatellite instability with neoadjuvant pembrolizumab and Mohs surgery
  Australasian Journal of Dermatology, 2022
• Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy
  Cancer Cell, 2022
• Pembrolizumab in the Treatment of Microsatellite Instability-High Sebaceous Carcinoma: A Case Report With Review of the Literature
  JCO Precision Oncology, 2020
• Carboplatin and Pembrolizumab Chemoimmunotherapy Achieves Remission in Recurrent, Metastatic Sebaceous Carcinoma
  Ophthalmic Plastic & Reconstructive Surgery, 2018
• Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma
  Journal for ImmunoTherapy of Cancer, 2018